Citation:

 Kassebaum NJ, Arora M, Barber RM, Bhutta ZA, Brown J, Carter A, et al.; GBD 2015 DALYs and
HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315
diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for
the Global Burden of Disease Study 2015. Lancet. 2016 Oct;388(10053):1603–58.

 Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al.; GBD 2015 Mortality and
Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality,
and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the
Global Burden of Disease Study 2015. Lancet. 2016 Oct;388(10053):1459–544.

 Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to
treatment for end-stage kidney disease: a systematic review. Lancet. 2015
May;385(9981):1975–82.

 Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, et al. International Society of
Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a
human rights case for nephrology. Lancet. 2015 Jun;385(9987):2616–43.

 Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical
practice guideline for the evaluation and management of chronic kidney disease. Kidney Int
Suppl. 2013;3(1):1–150.

 Chan JC, Gregg EW, Sargent J, Horton R. Reducing global diabetes burden by implementing
solutions and identifying gaps: a Lancet Commission. Lancet. 2016 Apr;387(10027):1494–5.

 Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of

hypertension: analysis of worldwide data. Lancet. 2005 Jan;365(9455):217–23.

 Dr. Frank Maddux 10/29/2019, Fresenius Medical

Care,https://www.freseniusmedicalcare.com/en/news/maddux-management-board/

 Merrill JP, Murray JE, Harrison JH. Successful homotransplantation of the human kidney
between identical twins. J Am Med Assoc (1956) 160(4):277–82.
doi:10.1001/jama.1956.02960390027008

 Starzl TE. The landmark identical twin case. J Am Med Assoc (1984) 251(19):2572–3.
doi:10.1001/jama.251.19.2572

 Medin C, Elinder CG, Hylander B, Blom B, Wilczek H. Survival of patients who have been on a
waiting list for renal transplantation. Nephrol Dial Transplant (2000) 15(5):701–4.
doi:10.1093/ndt/15.5.701
 Organ Donation and Transplantation Activities 2014. The Global Observatory on Donation and
Transplantation (GODT) Data. The WHO-ONT Collaboration (2016). Available
from: http://www.transplant-observatory.org/data-reports-2014/

 United States Renal Data System. 2015 USRDS Annual Data Report: Epidemiology of Kidney
Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of
Diabetes and Digestive and Kidney Diseases (2015).

 Praditpornsilpa K, Lekhyananda S, Premasathian N, Kingwatanakul P, Lumpaopong A, Gojaseni P,

et al. Prevalence trend of renal replacement therapy in Thailand: impact of health economics
policy. J Med Assoc Thai (2011) 94(Suppl 4):S1–6.

 Hooi LS, Wong HS, Morad Z. Prevention of renal failure: the Malaysian experience. Kidney Int
Suppl (2005) 94:S70–4. doi:10.1111/j.1523-1755.2005.09418.x

 Lim YN, Lim TO, Lee DG, Wong HS, Ong LM, Shaariah W, et al. A report of the Malaysian dialysis
registry of the National Renal Registry, Malaysia. Med J Malaysia (2008) 63(Suppl C):5–8.

 Population Reference Bureau. Average Life Expectancy in Asia for Those Born in 2015, by Gender
and Region (in Years). New York, NY (2016). Available
from: https://www.statista.com/statistics/274516/life-expectancy-in-asia/

 World Bank. World Development Indicators. Washington, DC (2016). Available from:

http://wdi.worldbank.org/table/2.15#

 NKTI,2010 http://www.nkti.gov.ph/index.php/patients-and-visitors/kidney-health-plus
 (Korean J Intern Med. 2013 May; 28(3): 274–284,
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654122/)

 Carolyn Rickard-Brideau, (March 31, 2015) AIA, LEED AP BD+C, Provisional WELL AP is the senior
partner and office president for the Washington, D.C. office of Little, an international
architecture and design firm. With over 30 years in practice, she is a leader in WELL certification
and is one of only 80 Provisional WELL Accredited Professionals in the
US.https://www.metropolismag.com/interiors/whats-the-next-big-step-in-building-salutogenic-
design/

 HealWell , January 12, 2016–,Enhancing the healing environment in hospitals, using the natural
power of light.

 DOH4A,October 11, 2018, https://pia.gov.ph/news/articles/1013551

 Combes G, Allen K, Sein K, Girling A, Lilford R,Implement Sci. 2015 Oct 27; 10():148., Taking
hospital treatments home: a mixed methods case study looking at the barriers and success
factors for home dialysis treatment and the influence of a target on uptake rates.
 Kimmel PL,Kidney Int. 2001 Apr; 59(4):1599-613., Psychosocial factors in dialysis patients.

 Chilcot J, Spencer BW, Maple H, Mamode N

Transplantation. 2014 Apr 15; 97(7):717-21., Depression and kidney transplantation.

 Carolyn Rickard-Brideau, March 31, 2015, AIA, LEED AP BD+C, Provisional WELL AP is the
senior partner and office president for the Washington, D.C. office of Little, an international
architecture and design firm. With over 30 years in practice, she is a leader in WELL certification
and is one of only 80 Provisional WELL Accredited Professionals in the US.